pMV306hsp+Lux Citations (4)

Originally described in: Optimisation of bioluminescent reporters for use with mycobacteria.
Andreu N, Zelmer A, Fletcher T, Elkington PT, Ward TH, Ripoll J, Parish T, Bancroft GJ, Schaible U, Robertson BD, Wiles S PLoS One. 2010 May 24;5(5):e10777. PubMed Journal

---

Articles Citing pMV306hsp+Lux

Articles
Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis. Harbut MB, Vilcheze C, Luo X, Hensler ME, Guo H, Yang B, Chatterjee AK, Nizet V, Jacobs WR Jr, Schultz PG, Wang F. Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):4453-8. doi: 10.1073/pnas.1504022112. Epub 2015 Mar 23. PubMed
Novel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosis. Li Q, Karim AF, Ding X, Das B, Dobrowolski C, Gibson RM, Quinones-Mateu ME, Karn J, Rojas RE. Sci Rep. 2016 Jun 14;6:27566. doi: 10.1038/srep27566. PubMed
Reporter-Based Assays for High-Throughput Drug Screening against Mycobacterium abscessus. Gupta R, Netherton M, Byrd TF, Rohde KH. Front Microbiol. 2017 Nov 10;8:2204. doi: 10.3389/fmicb.2017.02204. eCollection 2017. PubMed
Evidence for Inhibition of Topoisomerase 1A by Gold(III) Macrocycles and Chelates Targeting Mycobacterium tuberculosis and Mycobacterium abscessus. Gupta R, Rodrigues Felix C, Akerman MP, Akerman KJ, Slabber CA, Wang W, Adams J, Shaw LN, Tse-Dinh YC, Munro OQ, Rohde KH. Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: AAC.01696-17. doi: 10.1128/AAC.01696-17. Print 2018 May. PubMed

If you have published an article using this material, please email us at to have your article added to this page.